Zobrazeno 1 - 10
of 360
pro vyhledávání: '"Gepants"'
Autor:
Shagun Singh, Caroline M. Kopruszinski, Moe Watanabe, David W. Dodick, Edita Navratilova, Frank Porreca
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Sexual dimorphism has been revealed for many neurological disorders including chronic pain. Prelicinal studies and post-mortem analyses from male and female human donors reveal sexual dimorphism of nociceptors at transcript, protein and func
Externí odkaz:
https://doaj.org/article/a3a604c1b7704044a984efcdec7d56f0
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Migraine, a prevalent neurological disorder, affects approximately 14.1% of the global population and disproportionately impacts females. This debilitating condition significantly compromises quality of life, productivity, and incurs high healthcare
Externí odkaz:
https://doaj.org/article/31c45c4877da4eefab5528ce0493914c
Autor:
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Princess Carmina, Batool Aldaher, Shadi Haddad, Yazan Bader
Publikováno v:
Neurology and Therapy, Vol 13, Iss 2, Pp 465-473 (2024)
Abstract Introduction The introduction of clacitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) has revolutionized the treatment of migraines. In clinical practice gepants might be considered as a valid option to treat acute attacks in
Externí odkaz:
https://doaj.org/article/5a5d294c06a149ed8eaeedc5afe616a2
Autor:
Taoufik Alsaadi, Deeb M. Kayed, Abubaker Al-Madani, Ali Mohamed Hassan, Derk Krieger, Naji Riachi, Pournamy Sarathchandran, Suhail Al-Rukn
Publikováno v:
Neurology and Therapy, Vol 13, Iss 2, Pp 257-281 (2024)
Abstract Introduction Migraine, characterized by recurrent headaches and often accompanied by other symptoms like nausea, vomiting, and sensitivity to light and sound, significantly impacts patients’ quality of life (QoL) and daily functioning. The
Externí odkaz:
https://doaj.org/article/820ee0eaa7554269adf8b434ef0e079b
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-5 (2023)
Abstract In this editorial we aim to provide potential therapeutic options in patients who do not benefit from treatment with CGRP(r) monoclonal antibodies. Based on current real-life studies and analysis of practical and economic aspects, we will an
Externí odkaz:
https://doaj.org/article/bda9b100263e460ab828c7cb2bed239d
Autor:
Taoufik Alsaadi, Deeb M. Kayed, Abubaker Al-Madani, Ali Mohamed Hassan, Alessandro Terruzzi, Derk Krieger, Naji Riachi, Pournamy Sarathchandran, Suhail Al-Rukn
Publikováno v:
Neurology and Therapy, Vol 12, Iss 6, Pp 1845-1865 (2023)
Abstract Introduction Migraine is a common debilitating neurological disorder affecting a large proportion of the general population. Calcitonin gene-related peptide (CGRP), a 37-amino acid neuropeptide, plays a key role in the pathophysiology of mig
Externí odkaz:
https://doaj.org/article/fb199cd62c0d4b66bf753c731aa313d7
Publikováno v:
Bulletin of the National Research Centre, Vol 47, Iss 1, Pp 1-4 (2023)
Abstract Background Migraine is a debilitating disorder that undoubtedly has a significant impact both clinically and socially. New treatment options are necessary in Iran due to issues with tolerance, interactions, contraindications, and the lack of
Externí odkaz:
https://doaj.org/article/184ce3d562504caf8dec1ecbeadea20d
Autor:
Aleksandra Kłos, Mateusz Pawlicki, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Greguła, Aleksnadra Mazurek, Wiktoria Wilanowska
Publikováno v:
Journal of Education, Health and Sport, Vol 56 (2024)
Introduction and purpose Migraine is a common disease mostly affecting women. It has a huge influence on patients’ life strongly decreasing its quality by cause of repetitive headache episodes and often comes with unpleasant and burdensome sympto
Externí odkaz:
https://doaj.org/article/67947ae438e04b36a594469df0122394
Calcitonin Gene-Related Peptide (CGRP)-Targeted Treatments—New Therapeutic Technologies for Migraine
Autor:
Linda Sangalli, Stefania Brazzoli
Publikováno v:
Future Pharmacology, Vol 3, Iss 1, Pp 117-131 (2023)
Migraine is ranked as the third most common disorder worldwide and is considered one of the most disabling neurological conditions. Its treatment has mostly relied on medications that were non-specifically developed for migraine, thus accompanied by
Externí odkaz:
https://doaj.org/article/7a2d36d155f345c094794fda0bebb9f2
Publikováno v:
Drugs in Context, Vol 11, Pp 1-10 (2022)
Migraine headaches are widespread, debilitating and considered a main cause of disability worldwide. Symptoms of migraines include unilateral, pulsating pain that can last for hours to days, frequently associated with photophobia and phonophobia, nau
Externí odkaz:
https://doaj.org/article/4b2fb2c77f24465e9cde52745e29b84d